Federated Hermes’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
– Sell
-93,500
Closed -$1.73M – 2282
2017
Q3
$1.73M Hold
93,500
– – 0.01% 985
2017
Q2
$1.55M Sell
93,500
-126,600
-58% -$1.76M ﹤0.01% 1048
2017
Q1
$3.04M Hold
220,100
– – 0.01% 745
2016
Q4
$4.17M Hold
220,100
– – 0.01% 612
2016
Q3
$4.88M Hold
220,100
– – 0.01% 575
2016
Q2
$4.02M Buy
220,100
+117,000
+113% +$2.01M 0.01% 606
2016
Q1
$1.88M Hold
103,100
– – 0.01% 863
2015
Q4
$1.74M Buy
103,100
+45,343
+79% +$770K 0.01% 929
2015
Q3
$1.04M Hold
57,757
– – ﹤0.01% 1083
2015
Q2
$1.49M Hold
57,757
– – ﹤0.01% 1031
2015
Q1
$1.26M Buy
+57,757
New +$1.25M ﹤0.01% 1105

Other funds holding ENTL

Federated Hermes's ENTL Position: Q4 2017 in Review

Federated Hermes sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q4 2017, closing a stake of 93,500 shares — an estimated $1.73M sold.

Federated Hermes first reported a position in ENTL in Q1 2015 and held it in 11 quarters. The position peaked at $4.88M in Q3 2016. 83 funds tracked by Wall St. Rank hold ENTL as of Q4 2017.

  • Federated Hermes reported no remaining Entellus Medical, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Federated Hermes sold 93,500 Entellus Medical, Inc. Common Stock shares in Q4 2017, an estimated $1.73M.
  • Federated Hermes first reported a position in Entellus Medical, Inc. Common Stock in Q1 2015 and held it in 11 quarters.
  • Federated Hermes's Entellus Medical, Inc. Common Stock position peaked at $4.88M in Q3 2016.
  • 83 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q4 2017.

Based on Federated Hermes's 13F filing for Q4 2017, filed 14 Feb 2018.